Document is current
Any future updates will be listed below
-
Authors
Dong, Peng https://orcid.org/0000-0003-4946-1409
Zhang, Shu https://orcid.org/0000-0003-2543-5943
Gandin, Valentina
Xie, Liangqi
Wang, Lihua
Lemire, Andrew L. https://orcid.org/0000-0002-0624-3789
Li, Wenhong
Otsuna, Hideo
Kawase, Takashi
Lander, Arthur D. https://orcid.org/0000-0002-4380-5525
Chang, Howard Y. https://orcid.org/0000-0002-9459-4393
Liu, Zhe J. https://orcid.org/0000-0002-3592-3150
-
Funding
Funding for this research was provided by:
Howard Hughes Medical Institute
Ministry of Science and Technology of the People's Republic of China (2023YFF0715200)
Chinese National Science Fund for Excellent Oversea Young Scholars Shenzhen Medical Research Fund
U.S. Department of Health & Human Services | National Institutes of Health (RM1-HG007735;R35-CA209919, R01-GM098151-01, U54-CA217378; R01-DE019638, RM1-HG007735;R35-CA209919)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
- License Information
-
More Information
Article History
Received: 8 February 2023
Accepted: 27 June 2024
First Online: 24 July 2024
Competing interests
: H.Y.C. is a cofounder of Accent Therapeutics, Boundless Bio, Cartography Biosciences and Orbital Therapeutics and is an advisor for 10x Genomics, Arsenal Biosciences and Spring Discovery. The other authors declare no competing interests.
